Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples